Conjunctival melanoma in the Netherlands: A nationwide study

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 1, 2005, Pages 75-82

  Missotten, Guy S ^a   Keijser, Sander ^a   De Ketzer, Rob J W ^a   De Wolff Rouendaal, Didi ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C; STRONTIUM 90; YTTRIUM 90;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONJUNCTIVA TUMOR; CONJUNCTIVAL MELANOMA; CONTROLLED STUDY; CRYOTHERAPY; FEMALE; HEALTH SURVEY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; NETHERLANDS; PAROTID GLAND CANCER; PRIORITY JOURNAL; RISK FACTOR; SKIN METASTASIS; TUMOR VOLUME;

CONJUNCTIVAL NEOPLASMS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 11144279267     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0344     Document Type: Article

References (38)

1. Folberg R, McLean IW, Zimmerman LE. Malignant melanoma of the conjunctiva. Hum Pathol. 1985;16:136-143.
2. Shields JA, Shields CL. Tumors of the conjunctiva and cornea. In: Smolin G, Tholft RA, eds. The Cornea: Scientific Foundations and Clinical Practice. 3rd ed. Boston: Little, Brown & Co. 1993:579-595.
3. Shields JA, Shields CL. Tumors of the conjunctiva. In: Stephenson CM, ed. Ophthalmic Plastic, Reconstructive and Orbital Surgery. Stoneham, MA: Butterworth-Heinemann; 1997:253-271.
4. Lommatzsch P, Lommatzsch R, Kirsch I, Fuhrmann P. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol. 1990;74:615-619.
5. Seregard S. Conjunctival melanoma: major review. Surv Ophthalmol. 1998;42:321-350.
6. Tuomaala S, Eskelin S, Tarkkanen A, Kivela T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci. 2002;43:3399-3408.
7. de Vries E, Schouten LJ, Visser O, Eggermont AM, Coebergh FW. Rising trends in the incidence of and mortality from cutaneous melanoma in The Netherlands: a Northwest to Southeast gradient? Eur J Cancer. 2003;39:1439-1446.
8. Yu G-P, Hu D-N, McCormick S, Finger P. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol. 2003;135:800-806.
9. Bergman L, Seregard S, Nilsson B, et al. Incidence of uveal melanoma in Sweden from 1960-1998. Invest Ophthalmol Vis Sci. 2002;43:2579-2583.
10. de Wolff-Rouendaal D, Oosterhuis JA. Conjunctival melanoma in the Netherlands: a follow-up study. Doc Ophthalmol. 1983;56:49-54.
11. Fuchs U, Kivelä T, Liesto K, Tarkkanen A. Prognosis of conjunctival melanomas in relation to histopathological features. Br J Cancer. 1989;59:261-267.
12. de Wolff-Rouendaal D. Conjunctival melanoma in the Netherlands: a clinicopathological and follow-up study. Thesis. Leiden, The Netherlands: University of Leiden; 1990.
13. Seregard S, Kock E. Conjunctival malignant melanoma in Sweden 1969-1991. Acta Ophthalmol. 1992;70:289-296.
14. De Potter P, Shields C, Shields J, Menduke H. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases. Br J Ophthalmol. 1993;77:624-630.
15. Paridaens AD, Minassian DC, McCartney AC, Hungerford JL. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol. 1994;78:252-259.
16. Norregaard JC, Gerner N, Jensen OA, Prause JU. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol. 1996;234:569-572.
17. Bobic-Radovanovic A, Latkovic Z, Marinkovic J, Radovanovic Z. Predictors of survival in malignant melanoma of the conjunctiva: a clinico-pathological and follow-up study. Eur J Ophthalmol. 1998;8:4-7.
18. Desjardins L, Poncet P, Levy C, et al. Facteurs pronostiques du melanoma malin de la conjonctive: etude anatomo-clinique sur 56 patients. J Fr Ophtalmol. 1999;22:315-321.
19. Shields CL. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Trans Am Ophthalmol Soc. 2000;98:471-492.
20. Shields C, Shields J, Gündüz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol. 2000;118:497-1507.
21. Werschnik C, Lommatzsch PK. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol. 2002;25:248-255.
22. Lommatzsch PK, Werschnik C. Das maligne Melanom der Bindehaut. Klinische Übersicht mit Empfehlungen zur Diagnose, Therapie und Nachsorge. Klin Monatsbl Augenheilkd. 2002;219:710-721.
23. de Wolff-Rouendaal D. Melanozytäre tumoren der bindehaut. In: Lommatzsch P, ed. Ophthalmologische Onkologie. Stuttgart, Germany: Enke; 1990:81-95.
24. Shields CL, Fasiudden A, Mashayekhi A, Shields JA. Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol. 2004;122:167-175.
25. Esmaeli B, Wang X, Youssef A, Gershenwald JE. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. Ophthalmology. 2001;108:2101-2105.
26. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172:902-908.
27. Lommatzsch P, Vollmar R. Ergebnisse der Beta-Therapie bei epibulbären tumoren. Klin Monatsbl Augenheilkd. 1964;144:856-871.
28. Lommatzsch P. Beta-ray treatment of malignant epithelial tumors of the conjunctiva. Am J Ophthalmol. 1976;81:198-206.
29. Lommatzsch P. Beta-ray treatment of conjunctival melanomas. Trans Ophthalmol Soc UK. 1977;97:378-380.
30. Anastassiou G, Heiligenhaus A, Bechrakis N, et al. Prognostic value of clinical and histopathological parameters in conjunctival melanoma retrospective study. Br J Ophthalmol. 2002;86:163-167.
31. Prayson R, Sebek B. Parotid gland malignant melanomas. Arch Patbol Lab Med. 2000;124:1780-1784.
32. Wilson MW, Fleming JC, Fleming RM, Haik BG. Sentinel node biopsy for orbital and ocular adnexal tumors. Ophthalmic Plast Reconstr Surg. 2001;17:338-345.
33. Esmaeli B, Eicher S, Popp J, et al. Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg. 2001;17:436-442.
34. Esmaeli B. Sentinel node biopsy in conjunctival lesions. In: Honavar SG, ed. XIIIth International Congress Ocular Oncology. Hyderabad, India; 2004:Abstract 35.
35. Esmaeli B, Reifler D, Prieto VG, et al. Conjunctival melanoma with a positive sentinel lymph node. Arch Ophthalmol. 2003;121:1779-1783.
36. Tuomaala S, Kivela T. Metastatic pattern and survival in disseminated conjunctival melanoma: implication for sentinel lymph node biopsy. Ophthalmology. 2004;111:816-821.
37. Paridaens AD, Minassian DC, McCartney AC, Hungerford JL. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol. 1994;78:520-528.
38. Shields C, Shields J. Tumors of the conjunctiva and cornea. Surv Ophthalmol. 2004;49:3-24.